- Home
- ETON vs USNA Comparison
ETON vs USNA Comparison
Compare ETON & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- USNA
- Stock Information
- Founded
- ETON 2017
- USNA 1992
- Country
- ETON United States
- USNA United States
- Employees
- ETON N/A
- USNA N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- USNA Medicinal Chemicals and Botanical Products
- Sector
- ETON Health Care
- USNA Health Care
- Exchange
- ETON Nasdaq
- USNA Nasdaq
- Market Cap
- ETON 498.8M
- USNA 565.5M
- IPO Year
- ETON 2018
- USNA 1996
- Fundamental
- Price
- ETON $18.35
- USNA $20.45
- Analyst Decision
- ETON Strong Buy
- USNA Hold
- Analyst Count
- ETON 3
- USNA 1
- Target Price
- ETON $29.67
- USNA $36.00
- AVG Volume (30 Days)
- ETON 249.9K
- USNA 278.3K
- Earning Date
- ETON 11-06-2025
- USNA 10-22-2025
- Dividend Yield
- ETON N/A
- USNA N/A
- EPS Growth
- ETON N/A
- USNA N/A
- EPS
- ETON N/A
- USNA 0.89
- Revenue
- ETON $58,181,000.00
- USNA $912,670,000.00
- Revenue This Year
- ETON $105.25
- USNA $9.77
- Revenue Next Year
- ETON $40.84
- USNA $2.69
- P/E Ratio
- ETON N/A
- USNA $22.08
- Revenue Growth
- ETON 85.40
- USNA 5.88
- 52 Week Low
- ETON $8.24
- USNA $18.70
- 52 Week High
- ETON $23.00
- USNA $41.84
- Technical
- Relative Strength Index (RSI)
- ETON 45.34
- USNA 31.92
- Support Level
- ETON $18.00
- USNA $19.45
- Resistance Level
- ETON $18.92
- USNA $21.15
- Average True Range (ATR)
- ETON 0.83
- USNA 0.88
- MACD
- ETON -0.12
- USNA 0.15
- Stochastic Oscillator
- ETON 45.30
- USNA 63.47
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About USNA USANA Health Sciences Inc.
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.